Perseus Proteomics Inc. (TYO:4882)
Japan · Delayed Price · Currency is JPY 409.00
-1.00 (-0.24%)
Aug 7, 2025, 9:39 AM JST
Accolade Market Cap
Perseus Proteomics has a market cap or net worth of 6.05 billion as of August 6, 2025. Its market cap has decreased by -9.51% in one year.
Market Cap
6.05B
Enterprise Value
4.38B
Revenue
120.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
$409.00
Market Cap Chart
Since June 22, 2021, Perseus Proteomics's market cap has decreased from 10.12B to 6.05B, a decrease of -40.25%. That is a compound annual growth rate of -11.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2025 | 6.05B | -27.00% |
| Dec 30, 2024 | 8.28B | 13.70% |
| Dec 29, 2023 | 7.29B | 97.33% |
| Dec 30, 2022 | 3.69B | -20.91% |
| Dec 30, 2021 | 4.67B | -53.87% |
| Jun 22, 2021 | 10.12B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chugai Pharmaceutical | 12.11T |
| Daiichi Sankyo Company | 6,600.46B |
| Takeda Pharmaceutical Company | 6,582.24B |
| HOYA Corporation | 6,270.76B |
| Otsuka Holdings | 3,913.98B |
| Terumo | 3,759.91B |
| Astellas Pharma | 2,786.62B |
| Shionogi & | 2,203.53B |